Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Dec 1, 2009


Randox Laboratories last week launched several multi-marker drugs-of-abuse testing arrays. The biochips enable the analysis of up to 10 drug classes from a single patient sample.

Two drugs-of-abuse arrays are available: DoA array I contains markers for amphetamine, methamphetamine, barbituates, benzodiazepine 1 & 2, cannabinoids, cocaine metabolite, methadone, opiates, and phencyclidine; DoA array II enables testing for buprenorphine, fentanyl, generic opioids, ketamine, LSD, MDMA, methaqualone, oxycodone 1 & 2, and propoxyphene. Creatinine is also included on the arrays as a marker of adulteration when testing urine samples. Both arrays are validated for use with urine and whole blood.

The biochips are designed for use with Randox's line of Evidence instruments.

Ocimum Biosolutions said last week that the National Cancer Institute has awarded its Biotracker laboratory information management system bronze-level compatibility certification for the Cancer Biomedical Informatics Grid.

Bronze compatibility certification guarantees that Biotracker LIMS is compliant with caBIG guidelines in four areas: programmatic access to data; use of controlled vocabularies; use and accessibility of data elements and metadata; and availability of a diagrammatic representation of the information model used.

DNAVision has been awarded Illumina CSPro certification to offer Infinium genotyping in its Belgium-based lab. DNAVision will now be able to offer Illumina genotyping arrays to European and other customers.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.